Coxsackie (BioActive Nutritional, Inc.)


Welcome to the PulseAid listing for the Coxsackie drug offered from BioActive Nutritional, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: BioActive Nutritional, Inc.
NON-PROPRIETARY NAME: Coxsackie B1, B4
SUBSTANCE NAME: HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2012-10-09
END MARKETING DATE: 0000-00-00


Coxsackie HUMAN OTC DRUG Details:

Item DescriptionCoxsackie from BioActive Nutritional, Inc.
LABELER NAME: BioActive Nutritional, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200; 200([hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2012-10-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43857-0111_e951e1e5-bf9d-4ca4-82fd-090e6e2039a7
PRODUCT NDC: 43857-0111
APPLICATION NUMBER:

Other HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BioActive Nutritional, Inc.Coxsackie